Join Now
(also known as Filgrastim)
Filgrastim, pegfilgrastim, and sargramostim are synthetic (man-made) versions of substances naturally produced in your body. These substances, called colony stimulating factors, help the bone marrow to make new white blood cells.
When certain cancer medicines fight your cancer cells, they also affect those whi... continue
More Information About Neupogen
Treatment Success Rate
| Top 5 Communities | ||
| Condition | Members | Success |
| Acute Myelogenous Leuke... | 15 |
80% |
| Hepatitis C | 5 |
80% |
| Acute Lymphocytic Leuke... | 5 |
100% |
| Chronic Lymphocytic Leu... | 3 |
100% |
| Chronic Myelogenous Leu... | 2 |
100% |
Overall, 89% (36
Members)
find Neupogen helpful
Neupogen Reviews
Not Working
Low white count down to 1.2. even with shots still going down. My actual bones hurt, oh yeah and more head aches.
Working / Worked
Working / Worked
Working / Worked
Working / Worked
Working / Worked
Working / Worked
Working / Worked
Working / Worked
Working / Worked
Showing 21 - 30 of 39 Reviews
Discussions
-
Do you know about "Filgrastim" (Neupogen)
Sunnygal - Your doc is right. Low WBC's, RBC's and platelets are all different, and treated differently. There is a drug called Epogen for low RBC's ... [More] -
Do you know about "Filgrastim" (Neupogen)
Neupogen has been around for as long as I can remember - mid-1990's at least. It's given fairly routinely to women with breast & ovarian cancers, ... [More] -
Do you know about "Filgrastim" (Neupogen)
My white count was down on #4 a few weeks ago not low enough to delay treatment but I was given a shot of Pegfilgrastim on the day my pump was removed... [More] -
Do you know about "Filgrastim" (Neupogen)
It's a stimulator of bone marrow to produce WBC. Injected subcutaneously. Side effect are rare. That's what I heard, never got it myself. [More] -
Do you know about "Filgrastim" (Neupogen)
They want to start me on Filgrastim the day after tomorrow (after chemo # 5, yea) It's because my blood counts are almost always down. I get pushed... [More]
